cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results
cbdMD (NYSE American: YCBD) has announced it will host a conference call on Thursday, February 13, 2025, at 4:20 p.m. Eastern Time to discuss the company's financial results for the first quarter of fiscal year 2025, ended December 31, 2024, and business progress.
The conference call will be accessible via multiple channels, including USA/Canada toll-free number (844-763-8274) and International number (647-484-8814). A replay will be available through USA/Canada (855-669-9658) and International (412-317-0088) numbers using passcode 7970691. Additionally, a webcast replay will be accessible through March 13, 2026.
cbdMD (NYSE American: YCBD) ha annunciato che terrà una conference call giovedì 13 febbraio 2025, alle 16:20 ora orientale per discutere i risultati finanziari dell'azienda per il primo trimestre dell'anno fiscale 2025, chiuso il 31 dicembre 2024, e i progressi aziendali.
La conference call sarà accessibile attraverso più canali, incluso il numero verde USA/Canada (844-763-8274) e il numero internazionale (647-484-8814). Una registrazione sarà disponibile attraverso i numeri USA/Canada (855-669-9658) e internazionale (412-317-0088) usando il codice di accesso 7970691. Inoltre, una registrazione in streaming sarà accessibile fino al 13 marzo 2026.
cbdMD (NYSE American: YCBD) ha anunciado que realizará una llamada de conferencia el jueves 13 de febrero de 2025, a las 4:20 p.m. Hora del Este para discutir los resultados financieros de la empresa para el primer trimestre del año fiscal 2025, que finalizó el 31 de diciembre de 2024, y el progreso empresarial.
La llamada de conferencia será accesible a través de múltiples canales, incluyendo el número gratuito de EE. UU./Canadá (844-763-8274) y el número internacional (647-484-8814). Una grabación estará disponible a través de los números de EE. UU./Canadá (855-669-9658) y internacional (412-317-0088) utilizando el código de acceso 7970691. Además, una repetición de la transmisión por web estará disponible hasta el 13 de marzo de 2026.
cbdMD (NYSE American: YCBD)가 2025년 2월 13일 목요일 오후 4시 20분 동부 표준시에 회의 전화를 개최하여 2024년 12월 31일에 종료된 2025 회계연도 1분기 재무 결과 및 사업 진행 상황에 대해 논의할 것이라고 발표했습니다.
회의 전화는 미국/캐나다 무료 전화번호 (844-763-8274) 및 국제 전화번호 (647-484-8814)를 포함한 여러 경로를 통해 접근할 수 있습니다. 재생은 미국/캐나다 (855-669-9658) 및 국제 (412-317-0088) 번호를 통해 액세스 코드 7970691을 사용하여 이용할 수 있습니다. 추가로, 웹캐스트 재생은 2026년 3월 13일까지 접근 가능합니다.
cbdMD (NYSE American: YCBD) a annoncé qu'il tiendra une conférence téléphonique le jeudi 13 février 2025, à 16 h 20, heure de l'Est, pour discuter des résultats financiers de l'entreprise pour le premier trimestre de l'exercice 2025, terminé le 31 décembre 2024, et des avancées de l'entreprise.
La conférence sera accessible par plusieurs canaux, y compris un numéro sans frais pour les États-Unis/Canada (844-763-8274) et un numéro international (647-484-8814). Une rediffusion sera disponible via les numéros USA/Canada (855-669-9658) et international (412-317-0088) avec le code d'accès 7970691. De plus, une rediffusion de la webcast sera accessible jusqu'au 13 mars 2026.
cbdMD (NYSE American: YCBD) hat angekündigt, dass am Donnerstag, den 13. Februar 2025, um 16:20 Uhr Eastern Time eine Telefonkonferenz stattfinden wird, um die finanziellen Ergebnisse des Unternehmens für das erste Quartal des Geschäftsjahres 2025, das am 31. Dezember 2024 endete, sowie den geschäftlichen Fortschritt zu besprechen.
Die Telefonkonferenz wird über mehrere Kanäle zugänglich sein, einschließlich einer kostenlosen Nummer für die USA/Kanada (844-763-8274) und einer internationalen Nummer (647-484-8814). Eine Wiederholung wird unter den USA/Kanada Nummern (855-669-9658) und international (412-317-0088) mit dem Zugangscode 7970691 verfügbar sein. Darüber hinaus ist eine Aufzeichnung des Webcasts bis zum 13. März 2026 zugänglich.
- None.
- None.
Charlotte, North Carolina--(Newsfile Corp. - February 7, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, February 13, 2025, to discuss the company's December 31, 2024 first quarter of fiscal year 2025 financial results and business progress.
CONFERENCE CALL DETAILS
| Thursday, February 13, 2025, 4:20 p.m. Eastern Time | ||
| USA/Canada: | 844-763-8274 | |
| International: | 647-484-8814 | |
| Teleconference Replay dial in: | ||
| USA/Canada: | 855-669-9658 | |
| International: | 412-317-0088 | |
| Replay Passcode: | 7970691 | |
| Webcast/Webcast Replay link - available through March 13, 2026: | ||
| https://www.gowebcasting.com/13965 | ||
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products, including NSF Certified for Sport® products, as well as our new Full Spectrum products. Our cbdMD brand currently includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including our Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our ATRx brand of natural functional mushroom support. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD oil and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, or ATRxlabs.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.1 THC-free is defined as below the level of detection using validated scientific analytical tools.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240114
FAQ
When will YCBD report its Q1 FY2025 earnings?
How can investors access YCBD's Q1 2025 earnings call?
How long will YCBD's Q1 2025 earnings call replay be available?
What period does YCBD's upcoming earnings report cover?
